AAPL297.11+2.81 (+0.95%) ▲|ABBV233.23-1.53 (-0.65%) ▼|ABT91.02+0.49 (+0.54%) ▲|ACN128.32+1.31 (+1.03%) ▲|ADBE200.14+2.71 (+1.37%) ▲|AMAT587.97+2.09 (+0.36%) ▲|AMD518.31-1.54 (-0.30%) ▼|AMGN351.38+4.37 (+1.26%) ▲|AMT174.81-4.57 (-2.55%) ▼|AMZN241.29+7.18 (+3.07%) ▲|AVGO385.58+5.43 (+1.43%) ▲|AXP342.40+4.62 (+1.37%) ▲|BA221.13+4.42 (+2.04%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG183.47+14.53 (+8.60%) ▲|BLK984.16-31.17 (-3.07%) ▼|BMY55.29-0.25 (-0.44%) ▼|BNY145.71-1.58 (-1.07%) ▼|BRK-B496.34+3.53 (+0.72%) ▲|C144.26-0.71 (-0.49%) ▼|CAT1,000.22+15.98 (+1.62%) ▲|CL92.42+0.99 (+1.08%) ▲|CMCSA22.72-0.08 (-0.35%) ▼|COF202.07+4.26 (+2.15%) ▲|COP106.34-3.63 (-3.30%) ▼|COST962.15+4.47 (+0.47%) ▲|CRM155.16+1.74 (+1.13%) ▲|CSCO122.07+0.92 (+0.76%) ▲|CVS100.14-1.43 (-1.41%) ▼|CVX170.95-5.03 (-2.86%) ▼|DE607.33+15.39 (+2.60%) ▲|DHR188.00+9.03 (+5.05%) ▲|DIS103.90+0.37 (+0.36%) ▲|DUK125.22+0.17 (+0.14%) ▲|EMR143.84+0.70 (+0.49%) ▲|FDX312.67-4.57 (-1.44%) ▼|GD345.92-4.43 (-1.26%) ▼|GE367.75+11.28 (+3.16%) ▲|GEV1,061.97+26.99 (+2.61%) ▲|GILD125.53+0.48 (+0.38%) ▲|GM79.72+0.77 (+0.98%) ▲|GOOG351.73+5.65 (+1.63%) ▲|GOOGL352.40+6.31 (+1.82%) ▲|GS1,081.71-12.73 (-1.16%) ▼|HD338.99+14.54 (+4.48%) ▲|HON228.52+6.15 (+2.76%) ▲|IBM263.03-1.91 (-0.72%) ▼|INTC135.30+3.02 (+2.28%) ▲|INTU266.49+8.44 (+3.27%) ▲|ISRG404.56+1.38 (+0.34%) ▲|JNJ239.90+0.82 (+0.34%) ▲|JPM332.88-1.27 (-0.38%) ▼|KO81.26+0.95 (+1.18%) ▲|LIN520.77+8.51 (+1.66%) ▲|LLY1,106.33-0.76 (-0.07%) ▼|LMT496.16-7.51 (-1.49%) ▼|LOW221.27+7.73 (+3.62%) ▲|LRCX370.22-1.11 (-0.30%) ▼|MA496.11+8.04 (+1.65%) ▲|MCD273.96+2.30 (+0.85%) ▲|MDLZ62.20+1.14 (+1.87%) ▲|MDT80.73+0.10 (+0.12%) ▲|META565.67+3.47 (+0.62%) ▲|MMM167.96+6.12 (+3.78%) ▲|MO71.51-0.10 (-0.14%) ▼|MRK119.57-0.03 (-0.03%) ▼|MS222.58-3.45 (-1.53%) ▼|MSFT374.78+0.84 (+0.22%) ▲|MU1,044.62-7.15 (-0.68%) ▼|NEE86.61+0.18 (+0.21%) ▲|NFLX72.42-0.40 (-0.55%) ▼|NKE41.88-0.51 (-1.19%) ▼|NOW95.66-0.28 (-0.29%) ▼|NVDA201.15+1.15 (+0.58%) ▲|ORCL160.23-4.93 (-2.99%) ▼|PEP143.07+1.02 (+0.72%) ▲|PFE24.34-0.38 (-1.52%) ▼|PG152.76+1.90 (+1.26%) ▲|PLTR115.34-1.37 (-1.17%) ▼|PM177.59-1.10 (-0.62%) ▼|QCOM199.00-5.13 (-2.51%) ▼|RTX185.80-0.59 (-0.32%) ▼|SBUX103.14+2.09 (+2.07%) ▲|SCHW91.77-1.41 (-1.51%) ▼|SO94.79-0.14 (-0.15%) ▼|SPG218.26+1.52 (+0.70%) ▲|T22.52-0.30 (-1.29%) ▼|TMO487.55+18.20 (+3.88%) ▲|TMUS183.52-1.05 (-0.57%) ▼|TSLA382.92+1.31 (+0.34%) ▲|TXN305.33+0.97 (+0.32%) ▲|UBER74.72+5.05 (+7.25%) ▲|UNH403.79-5.47 (-1.34%) ▼|UNP262.44+3.83 (+1.48%) ▲|UPS105.65-0.18 (-0.17%) ▼|USB60.10+0.05 (+0.08%) ▲|V332.54+4.06 (+1.23%) ▲|VZ45.84-0.90 (-1.92%) ▼|WFC83.96-0.17 (-0.20%) ▼|WMT119.78+0.36 (+0.30%) ▲|XOM135.81-3.92 (-2.81%) ▼|AAPL297.11+2.81 (+0.95%) ▲|ABBV233.23-1.53 (-0.65%) ▼|ABT91.02+0.49 (+0.54%) ▲|ACN128.32+1.31 (+1.03%) ▲|ADBE200.14+2.71 (+1.37%) ▲|AMAT587.97+2.09 (+0.36%) ▲|AMD518.31-1.54 (-0.30%) ▼|AMGN351.38+4.37 (+1.26%) ▲|AMT174.81-4.57 (-2.55%) ▼|AMZN241.29+7.18 (+3.07%) ▲|AVGO385.58+5.43 (+1.43%) ▲|AXP342.40+4.62 (+1.37%) ▲|BA221.13+4.42 (+2.04%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG183.47+14.53 (+8.60%) ▲|BLK984.16-31.17 (-3.07%) ▼|BMY55.29-0.25 (-0.44%) ▼|BNY145.71-1.58 (-1.07%) ▼|BRK-B496.34+3.53 (+0.72%) ▲|C144.26-0.71 (-0.49%) ▼|CAT1,000.22+15.98 (+1.62%) ▲|CL92.42+0.99 (+1.08%) ▲|CMCSA22.72-0.08 (-0.35%) ▼|COF202.07+4.26 (+2.15%) ▲|COP106.34-3.63 (-3.30%) ▼|COST962.15+4.47 (+0.47%) ▲|CRM155.16+1.74 (+1.13%) ▲|CSCO122.07+0.92 (+0.76%) ▲|CVS100.14-1.43 (-1.41%) ▼|CVX170.95-5.03 (-2.86%) ▼|DE607.33+15.39 (+2.60%) ▲|DHR188.00+9.03 (+5.05%) ▲|DIS103.90+0.37 (+0.36%) ▲|DUK125.22+0.17 (+0.14%) ▲|EMR143.84+0.70 (+0.49%) ▲|FDX312.67-4.57 (-1.44%) ▼|GD345.92-4.43 (-1.26%) ▼|GE367.75+11.28 (+3.16%) ▲|GEV1,061.97+26.99 (+2.61%) ▲|GILD125.53+0.48 (+0.38%) ▲|GM79.72+0.77 (+0.98%) ▲|GOOG351.73+5.65 (+1.63%) ▲|GOOGL352.40+6.31 (+1.82%) ▲|GS1,081.71-12.73 (-1.16%) ▼|HD338.99+14.54 (+4.48%) ▲|HON228.52+6.15 (+2.76%) ▲|IBM263.03-1.91 (-0.72%) ▼|INTC135.30+3.02 (+2.28%) ▲|INTU266.49+8.44 (+3.27%) ▲|ISRG404.56+1.38 (+0.34%) ▲|JNJ239.90+0.82 (+0.34%) ▲|JPM332.88-1.27 (-0.38%) ▼|KO81.26+0.95 (+1.18%) ▲|LIN520.77+8.51 (+1.66%) ▲|LLY1,106.33-0.76 (-0.07%) ▼|LMT496.16-7.51 (-1.49%) ▼|LOW221.27+7.73 (+3.62%) ▲|LRCX370.22-1.11 (-0.30%) ▼|MA496.11+8.04 (+1.65%) ▲|MCD273.96+2.30 (+0.85%) ▲|MDLZ62.20+1.14 (+1.87%) ▲|MDT80.73+0.10 (+0.12%) ▲|META565.67+3.47 (+0.62%) ▲|MMM167.96+6.12 (+3.78%) ▲|MO71.51-0.10 (-0.14%) ▼|MRK119.57-0.03 (-0.03%) ▼|MS222.58-3.45 (-1.53%) ▼|MSFT374.78+0.84 (+0.22%) ▲|MU1,044.62-7.15 (-0.68%) ▼|NEE86.61+0.18 (+0.21%) ▲|NFLX72.42-0.40 (-0.55%) ▼|NKE41.88-0.51 (-1.19%) ▼|NOW95.66-0.28 (-0.29%) ▼|NVDA201.15+1.15 (+0.58%) ▲|ORCL160.23-4.93 (-2.99%) ▼|PEP143.07+1.02 (+0.72%) ▲|PFE24.34-0.38 (-1.52%) ▼|PG152.76+1.90 (+1.26%) ▲|PLTR115.34-1.37 (-1.17%) ▼|PM177.59-1.10 (-0.62%) ▼|QCOM199.00-5.13 (-2.51%) ▼|RTX185.80-0.59 (-0.32%) ▼|SBUX103.14+2.09 (+2.07%) ▲|SCHW91.77-1.41 (-1.51%) ▼|SO94.79-0.14 (-0.15%) ▼|SPG218.26+1.52 (+0.70%) ▲|T22.52-0.30 (-1.29%) ▼|TMO487.55+18.20 (+3.88%) ▲|TMUS183.52-1.05 (-0.57%) ▼|TSLA382.92+1.31 (+0.34%) ▲|TXN305.33+0.97 (+0.32%) ▲|UBER74.72+5.05 (+7.25%) ▲|UNH403.79-5.47 (-1.34%) ▼|UNP262.44+3.83 (+1.48%) ▲|UPS105.65-0.18 (-0.17%) ▼|USB60.10+0.05 (+0.08%) ▲|V332.54+4.06 (+1.23%) ▲|VZ45.84-0.90 (-1.92%) ▼|WFC83.96-0.17 (-0.20%) ▼|WMT119.78+0.36 (+0.30%) ▲|XOM135.81-3.92 (-2.81%) ▼|
24.7 C
New York
Wednesday, June 24, 2026

Tag: joint

newssourceFORcompanyinformationcontent1marketreleases

Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established

Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established

Orange: Financial results at 30 June 2025

Press release
Paris, 29 July 2025

Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger – CrazyBulk

New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle mass and keep growing stronger with CrazyBulk’s legal strength training supplements. Explore the best stacks for real power gains in 2025
In the evolving world of performance fitness, strength building isn’t just about lifting heavier—it’s about training smarter, fueling properly, and choosing science-backed supplements that support sustainable muscle growth. As more athletes, fitness enthusiasts, and bodybuilders shift away from synthetic enhancers, a natural powerhouse is gaining serious ground: CrazyBulk strength training supplements.

Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger – CrazyBulk

New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle mass and keep growing stronger with CrazyBulk’s legal strength training supplements. Explore the best stacks for real power gains in 2025
In the evolving world of performance fitness, strength building isn’t just about lifting heavier—it’s about training smarter, fueling properly, and choosing science-backed supplements that support sustainable muscle growth. As more athletes, fitness enthusiasts, and bodybuilders shift away from synthetic enhancers, a natural powerhouse is gaining serious ground: CrazyBulk strength training supplements.

Regional Health Properties, Inc. Outlines Reasons for Regional Shareholders to Vote YES for Proposed Merger with SunLink Health Systems, Inc.

ATLANTA, GA, July 28, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care, today issues the following statement to its common stock shareholders.

Invesque Inc. Completes Disposition of 11 Seniors Housing Assets and Manager Changes at Four Other Properties

TORONTO, July 28, 2025 /CNW/ - Invesque Inc. (the "Company" or "Invesque") (TSX: IVQ) (TSX: IVQ.U) announced today that over the last 40 days...

Live Oak Bancshares, Inc. Prices Depositary Share Offering

WILMINGTON, N.C., July 28, 2025 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or the “Company”) announced the pricing of an underwritten offering of 4,000,000 depositary shares, each representing a 1/40th ownership interest in a share of 8.375% Fixed Rate Series A Non-Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”), with a liquidation preference of $25 per depositary share.

Weatherford Awarded Managed Pressure Drilling Contract for Woodside Energy’s Trion Deepwater Development

HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) ("Weatherford" or the "Company") today announced it has been awarded a significant contract to deliver Managed Pressure Drilling (MPD) services for the Trion project, a deepwater oil production project in Mexico operated by Woodside Petróleo Operaciones de México, S. de R.L. de C.V.

Whirlpool Corporation Announces Second-Quarter Results

Delivered sequential net sales growth across all segments, despite negative consumer sentiment impacting global demandDelivered significant cost take out of 100 basis points or...

Ultra Clean Reports Second Quarter 2025 Financial Results

HAYWARD, Calif., July 28, 2025 /PRNewswire/ -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT), today reported its financial results for the second quarter ended June...

Olin Announces Second Quarter 2025 Results

Highlights Second quarter 2025 net loss of ($1.3) million, or ($0.01) per diluted shareQuarterly adjusted EBITDA of $176.1 millionSecond quarter 2025 operating cash flow of...

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

Piramal Pharma Limited Announces Results for Q1FY26

MUMBAI, India, July 28, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, and health and wellness company, today...

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsJoint

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers